Akcea
Akcea is a biopharmaceutical company that develops RNA-targeted antisense therapeutics for the treatment of cardiometabolic lipid disorders.
Business Model:
Revenue: $489M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Akcea Information
Akcea was acquired by
Ionis Pharmaceuticals.
The acquisition happend on 2020-08-31.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 22 Boston Wharf Road
City: Boston
State: MA
Zip: 02210
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$668M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Akcea is a biopharmaceutical company that develops RNA-targeted antisense therapeutics for the treatment of cardiometabolic lipid disorders.
Contact Phone:
+16172070202
Contact Email:
Akcea went public on 7/14/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/14/2017
IPO Valuation:
$514M
Ticker Symbol:
AKCA
IPO Price:
$8/share
Amount Raised:
$125M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2017 | IPO | $125M | 12/2015 | Equity | $543.2M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
